Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Kura Oncology Inc buy tbackenh

Start price
€11.30
09.01.22 / 0%
Target price
€15.00
09.01.23
Performance (%)
25.66%
End price
€14.20
21.03.22
Summary
This prediction ended on 21.03.22 with a price of €14.20. The prediction had a final performance of 25.66%. This prediction was marked as speculative and is excluded from tbackenh's performance statistics.
Performance without dividends (%)
Name 1w 1m 1y
Kura Oncology Inc - - -
iShares Core DAX® 2.594% -1.158% 14.782%
iShares Nasdaq 100 3.553% -1.727% 43.265%
iShares Nikkei 225® 0.687% -8.354% 18.454%
iShares S&P 500 2.209% -0.942% 31.361%

According to tbackenh what are the pros and cons of Kura Oncology Inc for the foreseeable future?

Pros
Future proof or reliable business model
Cons
Higher risks for its business

Comments by tbackenh for this prediction

In the thread Kura Oncology Inc diskutieren

Buy Kura Oncology Inc

Prediction Buy
Perf. (%) 25.66%
Target price 15.000
Change
Ends at 09.01.23

Kursziel gesetzt auf 15,0